Last updated: 2026-10-13 09:21:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Cuprina Holdings (Cayman) Limited (CUPR) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2.03, with a market capitalisation of $11.84M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.45 to $14.80. This page covers its latest market performance, valuation, price trends and company information.
$11.84M | |
$2.08 | |
$76.00 | |
$1.45 | |
$2.06 | |
91.00 | |
96.83K | |
-- | |
$14.80 | |
$1.45 | |
-- | |
-- |
Cuprina Holdings (Cayman) Limited (CUPR) is trading at $2.03 in pre-market trading as of 2026-10-13 09:01:00, down 1.65% ($0.03) from the previous close of $2.06
Pre-market trading shows how investors are pricing CUPR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Cuprina Holdings (Cayman) Limited (CUPR) moved from $2.42 to $2.03, representing a decline of 16.28% ($0.39).
The stock traded between $1.62 and $2.54 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 93.84 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 4.4%
CUPR is currently trading at $2.03, placing it 4.4% of the way from its 52-week low of $1.45 to its 52-week high of $14.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
| Employees | 10 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cuprina Holdings (Cayman) Limited (CUPR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.